TEARSOLUTIONS, INC.

Profile

Company Names

TEARSOLUTIONS, INC.
TEARSOLUTIONS, LLC

Addresses

315 OLD IVY WAY, SUITE 301, CHARLOTTESVILLE, VA 22903

Phone Numbers

434-951-0444

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

VIRGINIA

Total Amount Raised:

$34,430,535.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-10-29 
$517,000.00 
$517,000.00 
$0.00 
Equity 
9
2024-09-25 
$12,709,989.00 
$14,025,198.00 
$1,315,209.00 
Equity 
8
2023-09-08 
$390,000.00 
$3,000,000.00 
$2,610,000.00 
 
7
2021-07-16 
$5,624,634.00 
$7,000,000.00 
$1,375,366.00 
 
6
2020-02-12 
$1,499,595.00 
$1,500,000.00 
$405.00 
Equity 
5
2019-03-04 
$1,332,364.00 
$1,332,364.00 
$0.00 
Equity 
4
2017-12-04 
$8,056,619.00 
$9,191,000.00 
$1,134,381.00 
Equity 
3
2017-01-18 
$3,410,334.00 
$5,320,668.00 
$1,910,334.00 
 
2
2014-10-30 
$500,000.00 
$3,000,000.00 
$2,500,000.00 
Equity 
1
2014-05-06 
$390,000.00 
$1,000,000.00 
$610,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOUIS 
ALPERN 
DIRECTOR
ANIL 
 
ASRANI 
EXECUTIVE OFFICER, DIRECTOR
ANIL 
ASRANI 
EXECUTIVE OFFICER, DIRECTOR
JENS 
 
BIERTUMPEL 
DIRECTOR
LEONARD 
 
BORRMANN 
DIRECTOR
MICHELLE 
 
CARPENTER 
EXECUTIVE OFFICER
ALEXEY 
 
CHERNUSHKIN 
DIRECTOR
ROBERT 
DEMPSEY 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
GADEK 
EXECUTIVE OFFICER, DIRECTOR
TOM 
 
GADEK 
EXECUTIVE OFFICER, DIRECTOR
LAURIE 
 
GORDON 
EXECUTIVE OFFICER
BRUCE 
 
KUPER 
DIRECTOR
BRUCE 
 
KUPPER 
DIRECTOR
BRUCE 
P. 
KUPPER 
DIRECTOR
GORDON 
 
LAURIE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GORDON 
LAURIE 
EXECUTIVE OFFICER
GORDON 
W. 
LAURIE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MARK 
 
LOGAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MARK 
LOGAN 
DIRECTOR
MARK 
B. 
LOGAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MARC 
 
ODRICH 
EXECUTIVE OFFICER
JAMES 
RAMEY 
DIRECTOR
COLIN 
 
ROLPH 
EXECUTIVE OFFICER
COLIN 
ROLPH 
EXECUTIVE OFFICER
COLIN 
M. 
ROLPH 
EXECUTIVE OFFICER
AMIR 
 
SHOJAEI 
DIRECTOR
AMIR 
SHOJAEI 
DIRECTOR
MAC 
 
THOMPSON 
EXECUTIVE OFFICER
W. MCILWAINE 
 
THOMPSON, JR. 
EXECUTIVE OFFICER
WILLIAM 
MCILWAINE 
THOMPSON, JR. 
EXECUTIVE OFFICER
ALEXEY 
 
VINOGRADOV 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2023-09-08 
D
BIOTECHNOLOGY 
 
NO REVENUES 
 
2021-07-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-03-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-03-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-04 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2017-01-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2017-01-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2014-05-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#